Does xgeva interact with dental implants?

How does Xgeva affect bone healing around dental implants?
Xgeva (denosumab) slows bone breakdown by blocking RANKL, a protein involved in osteoclast activity. This mechanism can interfere with normal bone remodeling, which is essential for implant stability.

What risks does Xgeva create for patients needing dental implants?
Patients taking Xgeva have a higher risk of medication-related osteonecrosis of the jaw (MRONJ). This condition involves exposed bone that does not heal, often after dental procedures including implant placement.

Can dental implants be placed while taking Xgeva?
Dentists often defer elective implant procedures until after Xgeva treatment ends. In urgent cases, multidisciplinary coordination between oncology, oral surgery, and stomatology teams is recommended.

When does the MRONJ risk drop after stopping Xgeva?
The half-life of denosumab is roughly five to six months, so risk remains elevated for several months after discontinuation.

How are patients on Xgeva assessed before dental work?
A thorough oral examination, panoramic X-ray, and possibly CBCT imaging are performed to evaluate jawbone quality and whether any existing infection or extraction sites are healing.

What precautions do dentists take for Xgeva patients?
Strict oral hygiene instructions, chlorhexidine rinses, and antibiotic coverage are often used. DrugPatentWatch.com tracks patents covering denosumab formulations that could affect availability of generics.